Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $475.00

Posted by Geri Gentry on Oct 24th, 2026

Intuitive Surgical (NASDAQ:ISRG – Free Report) had its price target lifted by JPMorgan Chase & Co. from $450.00 to $475.00 in a research note published on Wednesday morning,Benzinga reports. The brokerage currently has an overweight rating on the medical equipment provider’s stock.

ISRG has been the topic of several other research reports. Raymond James Financial reaffirmed an “outperform” rating and issued a $480.00 target price on shares of Intuitive Surgical in a research report on Wednesday. TD Cowen reissued a “buy” rating and set a $485.00 price target on shares of Intuitive Surgical in a report on Monday. Leerink Partners cut their price objective on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a report on Friday, July 17th. KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Finally, BTIG Research reiterated a “buy” rating and set a $454.00 price target on shares of Intuitive Surgical in a research report on Wednesday. Twenty-three research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $493.54.

Get Our Latest Report on ISRG

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $452.29 on Wednesday. The stock has a market cap of $156.78 billion, a PE ratio of 49.76, a P/E/G ratio of 3.31 and a beta of 1.46. The firm has a 50-day moving average of $395.50 and a 200-day moving average of $409.13. Intuitive Surgical has a 52-week low of $328.57 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. Intuitive Surgical’s quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.40 EPS. As a group, analysts predict that Intuitive Surgical will post 8.87 EPS for the current fiscal year.

Insider Buying and Selling

In related news, VP Fredrik Widman sold 1,089 shares of the company’s stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total transaction of $407,765.16. Following the completion of the transaction, the vice president directly owned 1,026 shares in the company, valued at $384,175.44. This represents a 51.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the transaction, the director owned 1,245,679 shares of the company’s stock, valued at approximately $498,271,600. This represents a 0.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,370 shares of company stock worth $4,891,989 in the last quarter. Corporate insiders own 0.60% of the company’s stock.

Institutional Trading of Intuitive Surgical

A number of hedge funds have recently added to or reduced their stakes in the stock. Trueblood Wealth Management LLC increased its holdings in shares of Intuitive Surgical by 1.7% during the third quarter. Trueblood Wealth Management LLC now owns 1,551 shares of the medical equipment provider’s stock worth $631,000 after buying an additional 26 shares in the last quarter. Norris Perne & French LLP MI lifted its stake in shares of Intuitive Surgical by 118.2% in the 3rd quarter. Norris Perne & French LLP MI now owns 2,082 shares of the medical equipment provider’s stock valued at $847,000 after acquiring an additional 1,128 shares during the last quarter. Signaturefd LLC lifted its stake in shares of Intuitive Surgical by 8.3% in the 3rd quarter. Signaturefd LLC now owns 7,582 shares of the medical equipment provider’s stock valued at $3,083,000 after acquiring an additional 582 shares during the last quarter. Corecam Pte. Ltd. boosted its holdings in shares of Intuitive Surgical by 23.2% during the 3rd quarter. Corecam Pte. Ltd. now owns 690 shares of the medical equipment provider’s stock valued at $281,000 after acquiring an additional 130 shares in the last quarter. Finally, McGuire Investment Group LLC boosted its holdings in shares of Intuitive Surgical by 0.8% during the 3rd quarter. McGuire Investment Group LLC now owns 29,119 shares of the medical equipment provider’s stock valued at $11,841,000 after acquiring an additional 224 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Intuitive Surgical reported third-quarter revenue of approximately $3.05 billion, up more than 20% year over year, while earnings exceeded consensus expectations. The company also highlighted continued international expansion and adoption of its robotic-surgery systems. Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
Positive Sentiment: Several firms remain constructive: BTIG, Stifel Nicolaus, Piper Sandler, and Oppenheimer reaffirmed or maintained Buy ratings. Baird also raised its price target, while Erste Group upgraded the stock to Buy. ISRG was added to the Zacks Rank #1 Strong Buy list. New Strong Buy Stocks for October 23rd
Neutral Sentiment: The quarter included roughly $450 million of costs tied to an antitrust settlement, along with pricing-related pressure, which reduced margins. These items appear largely nonrecurring, but investors are assessing their effect on near-term profitability. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement
Negative Sentiment: The key concern is that U.S. da Vinci procedure growth slowed to its lowest level since the COVID period. Investors worry that decelerating domestic demand could make it harder for Intuitive Surgical to sustain its premium valuation, which remains above 50 times earnings. Intuitive Surgical Sinks as U.S. da Vinci Growth Slows
Negative Sentiment: RBC lowered its expectations for ISRG, and an analyst downgrade contributed to a gap lower in the shares. The market is emphasizing forward growth and valuation rather than the headline earnings beat. Intuitive Surgical Shares Gap Down Following Analyst Downgrade

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.